Neurosense Therapeutics Stock Forecast

Sell candidate since Jun 16, 2026 Loss -15.94%

No changes to the price of Neurosense Therapeutics Ltd. stock on the last trading day (Monday, 22nd Jun 2026). During the last trading day the stock fluctuated 18.08% from a day low at $0.0769 to a day high of $0.0908. The price has fallen in 6 of the last 10 days and is down by -54.81% for this period.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -34.13% during the next 3 months and, with a 90% probability hold a price between $0.0246 and $0.122 at the end of this 3-month period.

NRSNW Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Neurosense Therapeutics Ltd. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.120 and $0.135. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, June 05, 2026, and so far it has fallen -54.81%. Further fall is indicated until a new bottom pivot has been found. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Neurosense Therapeutics Ltd. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.0805 and $0.0800. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Neurosense Therapeutics Ltd. finds support just below today's level at $0.0805. If this is broken, then the next support from accumulated volume will be at $0.0800 and $0.0736.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.0139 between high and low, or 18.08%. For the last week the stock has had daily average volatility of 93.98%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (NRSNW) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect Neurosense Therapeutics Ltd. to open at $0.0861, and during the day (based on 14 day Average True Range), to move between $0.0575 and $0.124, which gives a possible trading interval of +/-$0.0663 (+/-115.21%) up or down from last closing price. If Neurosense Therapeutics Ltd. takes out the full calculated possible swing range there will be an estimated 115.21% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.101 (10.80%) than the support at $0.0805 (11.25%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Neurosense Therapeutics Ltd. stock A Buy?

Neurosense Therapeutics Ltd. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -7.785 Strong Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2026 - $0.0861 ( 5.04%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk